These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19773793)

  • 21. Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials.
    Liao YWB; Wang TKM
    Coron Artery Dis; 2020 May; 31(3):260-265. PubMed ID: 31821195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial.
    Husted S; James S; Becker RC; Horrow J; Katus H; Storey RF; Cannon CP; Heras M; Lopes RD; Morais J; Mahaffey KW; Bach RG; Wojdyla D; Wallentin L;
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):680-8. PubMed ID: 22991347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
    Ganetsky VS; Hadley DE; Thomas TF
    Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of oral anticoagulants in patients after an acute coronary syndrome.
    Carreras ET; Mega JL
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):520-4. PubMed ID: 25614282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
    Reddy P; Giugliano RP
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical appraisal of the AUGUSTUS trial.
    Gremmel T; Sulzgruber P; Niessner A
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):187-188. PubMed ID: 31265054
    [No Abstract]   [Full Text] [Related]  

  • 27. Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials.
    Navarese EP; Verdoia M; Schaffer A; Suriano P; Kozinski M; Castriota F; De Servi S; Kubica J; De Luca G
    QJM; 2011 Jul; 104(7):561-9. PubMed ID: 21572108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome.
    Weitz JI
    Thromb Haemost; 2014 Nov; 112(5):924-31. PubMed ID: 25030773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome.
    Ahmad T; Davies R; Alagona P
    J Fam Pract; 2017 Feb; 66(2 Suppl):. PubMed ID: 29095443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Antiplatelet Therapy Plus Xa Factor Inhibitors in Patients with Coronary Heart Disease: A Meta-Analysis.
    Chen H; Chen C; Fang J; Wang R; Nie W; Yuan Q
    Med Sci Monit; 2019 Jul; 25():5473-5481. PubMed ID: 31335859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
    Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Nicolau JC; Henry P; Kedev S; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
    Circ Cardiovasc Interv; 2018 Jun; 11(6):e006084. PubMed ID: 29895599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focus on pharma in acute coronary syndrome.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):1-2. PubMed ID: 31909430
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel oral anticoagulants in acute coronary syndrome.
    Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
    Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.
    Tsu LV; Dager WE
    Ann Pharmacother; 2013 Apr; 47(4):573-7. PubMed ID: 23548645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [NOAC in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease].
    Gottsäter A
    Lakartidningen; 2018 Dec; 115():. PubMed ID: 30512135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivaroxaban 2.5 mg. No justification for using this anticoagulant after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):229-32. PubMed ID: 25964962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
    Faxon DP
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimizing the risks of anticoagulants and platelet inhibitors.
    Alexander KP; Peterson ED
    Circulation; 2010 May; 121(17):1960-70. PubMed ID: 20439812
    [No Abstract]   [Full Text] [Related]  

  • 39. [The ATLAS ACS 2-TIMI 51 study].
    Casella G; Pavesi PC; Magnani G; Ardissino D
    G Ital Cardiol (Rome); 2012 Oct; 13(10):625-30. PubMed ID: 23022965
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
    Steg PG; Mehta SR; Pollack CV; Bode C; Cohen M; French WJ; Hoekstra J; Rao SV; Ruzyllo W; Ruiz-Nodar JM; Sabaté M; Widimsky P; Kiss RG; Navarro Estrada JL; Hod H; Kerkar P; Guneri S; Sezer M; Ruda M; Nicolau JC; Cavallini C; Ebrahim I; Petrov I; Kim JH; Jeong MH; Ramos Lopez GA; Laanmets P; Kovar F; Gaudin C; Fanouillere KC; Minini P; Hoffman EB; Moryusef A; Wiviott SD; Sabatine MS;
    JAMA; 2013 Sep; 310(11):1145-55. PubMed ID: 23995608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.